Teladoc Health (TDOC) Stock Price, News & Analysis

Company Overview

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Key Stats

• Today's Range: $8.05 to $8.92
• 50-Day Range: $6.52 to $8.43
• 52-Week Range: $6.35 to $15.21
• Volume: 18.17 million shs
• Average Volume: 6.31 million shs
• Market Capitalization: $1.48 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.60
• Consensus Rating: Hold

Teladoc Health Stock Analysis - MarketRank™

Teladoc Health scored higher than 67% of companies evaluated by MarketBeat, and ranked 354th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.37, and is based on 7 buy ratings, 12 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Teladoc Health has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Teladoc Health are expected to grow in the coming year, from ($1.16) to ($0.98) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teladoc Health is -1.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teladoc Health is -1.42, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Teladoc Health has a P/B Ratio of 0.97. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

12.37% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Teladoc Health has recently decreased by 6.42%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Teladoc Health does not currently pay a dividend.

Dividend Growth

Teladoc Health does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

12.37% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Teladoc Health has recently decreased by 6.42%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.36

News Sentiment

Teladoc Health has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 14 news articles for Teladoc Health this week, compared to 8 articles on an average week.

Search Interest

34 people have searched for TDOC on MarketBeat in the last 30 days. This is an increase of 36% compared to the previous 30 days.

MarketBeat Follows

Only 3 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $128,189.00 in company stock.

Percentage Held by Insiders

Only 0.58% of the stock of Teladoc Health is held by insiders.

Percentage Held by Institutions

76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

TDOC Stock Analysis - Frequently Asked Questions

How have TDOC shares performed this year?

Teladoc Health's stock was trading at $9.09 at the beginning of 2025. Since then, TDOC shares have decreased by 7.3% and is now trading at $8.4270.
View the best growth stocks for 2025 here.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) posted its quarterly earnings data on Wednesday, February, 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by $0.07. The health services provider had revenue of $640.49 million for the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative trailing twelve-month return on equity of 11.01% and a negative net margin of 39.66%.
Read the conference call transcript.

Does Teladoc Health have any subsidiaries?

Teladoc Health subsidiaries include these companies: Livongo, Intouch Health, MedecinDirect, TelaDietitian, Advance Medical, Best Doctors, CogCubed, and more.

When did Teladoc Health IPO?

Teladoc Health (TDOC) raised $112 million in an initial public offering on Wednesday, July 1st 2015. The company issued 7,000,000 shares at $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

How do I buy shares of Teladoc Health?

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Teladoc Health investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Salesforce (CRM), Advanced Micro Devices (AMD) and PayPal (PYPL).

Company Calendar

• Last Earnings: 2/26/2025
• Today: 6/30/2025
• Next Earnings (Estimated): 7/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:TDOC
• CIK: 1477449
• Web: www.teladochealth.com
• Phone: (203) 635-2002
• Fax: N/A
• Employees: 5,500
• Year Founded: 2002

Price Target and Rating

• Average Stock Price Target: $9.60
• High Stock Price Target: $12.00
• Low Stock Price Target: $7.00
• Potential Upside/Downside: +13.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.37
• Research Coverage: 19 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($5.92)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.00 billion
• Net Margins: -39.66%
• Pretax Margin: -40.18%
• Return on Equity: -11.01%
• Return on Assets: -4.66%

Debt

• Debt-to-Equity Ratio: 0.70
• Current Ratio: 1.68
• Quick Ratio: 1.64

Sales & Book Value

• Annual Sales: $2.57 billion
• Price / Sales: 0.58
• Cash Flow: $5.58 per share
• Price / Cash Flow: 1.51
• Book Value: $8.66 per share
• Price / Book: 0.97

Miscellaneous

• Outstanding Shares: 175,430,000
• Free Float: 174,417,000
• Market Cap: $1.48 billion
• Optionable: Optionable
• Beta: 1.78